Effect of silibinin on the pharmacokinetics of nitrendipine in rabbits
- 5 October 2013
- journal article
- research article
- Published by Springer Nature in European Journal of Drug Metabolism and Pharmacokinetics
- Vol. 39 (4) , 277-281
Abstract
Silibinin, a major constituent of silymarin, is widely used for its hepatoprotective effects. This study investigated the effect of silibinin on the pharmacokinetics of oral nitrendipine in rabbits. In first set of experiment, male New Zealand rabbits were pretreated with silibinin (50 mg/kg, PO) for 7 days and on last day nitrendipine (10 mg/kg, PO) was administered. In second set, both silibinin and nitrendipine were coadministered to examine acute effect of silibinin on nitrendipine pharmacokinetics. The plasma concentration of nitrendipine was estimated by high performance liquid chromatography and different pharmacokinetic parameters were calculated using WinNonlin® software. Coadministration of silibinin had no significant effect on pharmacokinetics of nitrendipine when compared to control group. However, a 1.89–1.57-fold increase in area under the concentration-time curve and peak plasma concentration (C max), respectively, of nitrendipine was observed in silibinin pretreated group. The mean C max was 0.034 ± 0.005 μg/mL (nitrendipine alone) and 0.054 ± 0.006 μg/mL (nitrendipine after pretreatment with silibinin). The time to reach C max, elimination rate constant and elimination half-life of nitrendipine were not significantly different among control and silibinin treated groups. This study demonstrates that silibinin increase plasma concentration of nitrendipine. Henceforth, the pharmacodynamic influence of this interaction should be taken into consideration while prescribing nitrendipine to the patients already taking silymarin.Keywords
This publication has 25 references indexed in Scilit:
- Assessment of a dry extract from milk thistle (Silybum marianum) for interference with human liver cytochrome-P450 activitiesToxicology in Vitro, 2011
- Effects of Silibinin, Inhibitor of CYP3A4 and P-Glycoprotein in vitro, on the Pharmacokinetics of Paclitaxel after Oral and Intravenous Administration in RatsPharmacology, 2010
- Effect of continuous silymarin administration on oral talinolol pharmacokinetics in healthy volunteersXenobiotica, 2009
- Influence of Some Bioflavonoids on Transport of NitrendipineDrug Metabolism and Drug Interactions, 2008
- Effect of Milk Thistle (Silybum marianum) on the Pharmacokinetics of IrinotecanClinical Cancer Research, 2005
- Effect of silybin and its glycosides on the expression of cytochromes P450 1A2 and 3A4 in primary cultures of human hepatocytesJournal of Biochemical and Molecular Toxicology, 2005
- The effect of quercetin on the pharmacokinetics of verapamil and its major metabolite, norverapamil, in rabbitsJournal of Pharmacy and Pharmacology, 2004
- SILYBIN INACTIVATES CYTOCHROMES P450 3A4 AND 2C9 AND INHIBITS MAJOR HEPATIC GLUCURONOSYLTRANSFERASESDrug Metabolism and Disposition, 2004
- Effects of the Flavonoids Biochanin A, Morin, Phloretin, and Silymarin on P-Glycoprotein-Mediated TransportThe Journal of Pharmacology and Experimental Therapeutics, 2003
- Effect of Silybin and its congeners on human liver microsomal cytochrome P450 activitiesPhytotherapy Research, 2002